Join to View Full Profile
4025 N Sheridan RdChicago, IL 60613
Phone+1 773-388-1600
Fax+1 773-388-8936
Dr. Trinh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Roger Trinh is an internist in Chicago, IL. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice 18 years. He specializes in hiv/aids medicine.
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1999 - 2002- Northwestern University The Feinberg School of MedicineClass of 1999
Certifications & Licensure
IL State Medical License 2002 - 2026
American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis Start of enrollment: 2014 Nov 24
- A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- 8 citationsEfficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter Study.Robert J. Fontana, Sabela Lens, Stuart McPherson, Magdy Elkhashab, Victor Ankoma-Sey
Advances in Therapy. 2019-10-23 - 1 citationsEfficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without...Fred Poordad, Shahriar Sedghi, Paul J. Pockros, Natarajan Ravendhran, Robert Reindollar
Journal of Viral Hepatitis. 2019-08-01 - 30 citationsGlecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysisSteven L. Flamm, David Mutimer, Armen Asatryan, Stanley Wang, Jürgen K. Rockstroh
Journal of Viral Hepatitis. 2019-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
